Non-small cell lung cancer stem/progenitor cells are enriched in multiple distinct phenotypic subpopulations and exhibit plasticity

Cell Death and Disease

Volumn 3, Issue 7, 2012, Pages

  Akunuru, S ^a   Zhai, Q James ^b   Zheng, Y ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

cancer stem cells; EMT; lung cancer; plasticity; Rac1; self renewal

Indexed keywords

CD133 ANTIGEN; GUANOSINE TRIPHOSPHATASE; RAC1 PROTEIN; ALDEHYDE DEHYDROGENASE; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CANCER STEM CELL; CELL ACTIVITY; CELL DIFFERENTIATION; CELL SUBPOPULATION; CONTROLLED STUDY; ENZYME ACTIVITY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MICROENVIRONMENT; PHENOTYPIC PLASTICITY; PRIORITY JOURNAL; PROTEIN TARGETING; SNAIL; STOCHASTIC MODEL; APOPTOSIS; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; METABOLISM; PATHOLOGY; PHENOTYPE; RNA INTERFERENCE; TUMOR CELL CULTURE;

ALDEHYDE DEHYDROGENASE; ANTIGENS, CD; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; EPITHELIAL-MESENCHYMAL TRANSITION; GLYCOPROTEINS; HUMANS; NEOPLASTIC STEM CELLS; PEPTIDES; PHENOTYPE; RAC1 GTP-BINDING PROTEIN; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFORMING GROWTH FACTOR BETA1; TUMOR CELLS, CULTURED;

EID: 84864865194     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2012.93     Document Type: Article

References (37)

1. Shackleton M, Quintana E, Fearon ER, Morrison S.J. Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell 2009; 138: 822-829.
2. Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di Virgilio A et al. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 2008; 15: 504-514.
3. Ho MM, Ng AV, Lam S, Hung J.Y. Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res 2007; 67: 4827-4833.
4. Sun Y, Zheng S, Torossian A, Speirs CK, Schleicher S, Giacalone NJ et al. Role of insulin-like growth factor-1 signaling pathway in Cisplatin-resistant lung cancer cells. Int J Radiat Oncol Biol Phys 2012; 82: e563-e572.
5. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994; 367: 645-648.
6. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T et al. Identification of human brain tumour initiating cells. Nature 2004; 432: 396-401.
7. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003; 100: 3983-3988.
8. O0Brien CA, Pollett A, Gallinger S, Dick J.E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007; 445: 106-110.
9. Chiba T, Kita K, Zheng YW, Yokosuka O, Saisho H, Iwama A et al. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology 2006; 44: 240-251.
10. Akunuru S, Palumbo J, Zhai QJ, Zheng Y. Rac1 targeting suppresses human non-small cell lung adenocarcinoma cancer stem cell activity. PLoS One 2011; 6: e16951.
11. Levina V, Marrangoni AM, DeMarco R, Gorelik E, Lokshin A.E. Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties. PLoS One 2008; 3: e3077.
12. Deng S, Yang X, Lassus H, Liang S, Kaur S, Ye Q et al. Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers. PLoS One 2010; 5: e10277.
13. Sullivan JP, Spinola M, Dodge M, Raso MG, Behrens C, Gao B et al. Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling. Cancer Res 2010; 70: 9937-9948.
14. Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C, Weinberg RA et al. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 2009; 138: 645-659.
15. Roesch A, Fukunaga-Kalabis M, Schmidt EC, Zabierowski SE, Brafford PA, Vultur A et al. A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell 2010; 141: 583-594.
16. Gupta PB, Chaffer CL, Weinberg R.A. Cancer stem cells: mirage or reality? Nat Med 2009; 15: 1010-1012.
17. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133: 704-715.
18. Liu H, Patel MR, Prescher JA, Patsialou A, Qian D, Lin J et al. Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models. Proc Natl Acad Sci USA 2010; 107: 18115-18120.
19. Wicha MS, Liu S, Dontu G. Cancer stem cells: an old idea-a paradigm shift. Cancer Res 2006; 66: 1883-1890; discussion 1895-1886.
20. Kim JH, Jang YS, Eom KS, Hwang YI, Kang HR, Jang SH et al. Transforming growth factor beta1 induces epithelial-to-mesenchymal transition of A549 cells. J Korean Med Sci 2007; 22: 898-904.
21. Rho JK, Choi YJ, Lee JK, Ryoo BY, Na II, Yang SH et al. Epithelial to mesenchymal transition derived from repeated exposure to gefitinib determines the sensitivity to EGFR inhibitors in A549, a non-small cell lung cancer cell line. Lung Cancer 2009; 63: 219-226.
22. Yin L, Castagnino P, Assoian R.K. ABCG2 expression and side population abundance regulated by a transforming growth factor beta-directed epithelial-mesenchymal transition. Cancer Res 2008; 68: 800-807.
23. Lyons JG, Patel V, Roue NC, Fok SY, Soon LL, Halliday GM et al. Snail up-regulates proinflammatory mediators and inhibits differentiation in oral keratinocytes. Cancer Res 2008; 68: 4525-4530.
24. Thomson S, Petti F, Sujka-Kwok I, Mercado P, Bean J, Monaghan M et al. A systems view of epithelial-mesenchymal transition signaling states. Clin Exp Metastasis 2011; 28: 137-155.
25. Liton PB, Li G, Luna C, Gonzalez P, Epstein D.L. Cross-talk between TGF-beta1 and IL-6 in human trabecular meshwork cells. Mol Vision 2009; 15: 326-334.
26. Di Carlo E, Modesti A, Castrilli G, Landuzzi L, Allione A, de Giovanni C et al. Interleukin 6 gene-transfected mouse mammary adenocarcinoma: tumour cell growth and metastatic potential. J Pathol 1997; 182: 76-85.
27. Boiko AD, Razorenova OV, van de Rijn M, Swetter SM, Johnson DL, Ly DP et al. Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature 2010; 466: 133-137.
28. Dirks P. Cancer stem cells: invitation to a second round. Nature 2010; 466: 40-41.
29. Iliopoulos D, Hirsch HA, Wang G, Struhl K. Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion. Proc Natl Acad Sci USA 2011; 108: 1397-1402.
30. Gupta PB, Fillmore CM, Jiang G, Shapira SD, Tao K, Kuperwasser C et al. Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell 2011; 146: 633-644.
31. Chiou SH, Wang ML, Chou YT, Chen CJ, Hong CF, Hsieh WJ et al. Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem celllike properties and epithelial-mesenchymal transdifferentiation. Cancer Res 2010; 70: 10433-10444.
32. Yao Z, Fenoglio S, Gao DC, Camiolo M, Stiles B, Lindsted T et al. TGF-beta IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer. Proc Natl Acad Sci USA 2010; 107: 15535-15540.
33. Kardassis D, Murphy C, Fotsis T, Moustakas A, Stournaras C. Control of transforming growth factor beta signal transduction by small GTPases. FEBS J 2009; 276: 2947-2965.
34. Radisky DC, Levy DD, Littlepage LE, Liu H, Nelson CM, Fata JE et al. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 2005; 436: 123-127.
35. Santibanez JF, Kocic J, Fabra A, Cano A, Quintanilla M. Rac1 modulates TGF-beta1- mediated epithelial cell plasticity and MMP9 production in transformed keratinocytes. FEBS Lett 2010; 584: 2305-2310.
36. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan R.C. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 1996; 183: 1797-1806.
37. Guo F, Gao Y, Wang L, Zheng Y. p19Arf-p53 tumor suppressor pathway regulates cell motility by suppression of phosphoinositide 3-kinase and Rac1 GTPase activities. J Biol Chem 2003; 278: 14414-14419.